NEW YORK (GenomeWeb News) – Becton Dickinson said today that it and Hologic's Gen-Probe business have settled a patent dispute, and the company has been granted a license from Gen-Probe to make, use, and sell certain products that BD had been accused of infringing.

BD will make payments to Gen-Probe as part of the settlement, including upfront fees and ongoing royalties. BD did not specify the amounts of the payments but said they are not material to the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.